Moreover, the expression levels of these cell adhesion molecules were significantly associated with improved patient survival, further supporting the potential protective role of ALDH1A2 in prostate cancer progression through these cell adhesion molecules. This evidence concerns the gene ALDH1A2 and Familial prostate cancer.